SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (443)6/15/1999 8:55:00 PM
From: Biomaven  Read Replies (1) of 3158
 
Remember SUGN touched single digits at the end of last summer. Close on a 40% premium over the current price is something I will accept fairly happily with my few shares of common - no option holding for me on this one, alas.

I guess I'm a little surprised at the timing - would have thought SUGN might have waited a year or so before selling. The interesting thing is that PNU was prepared to undergo some minor dilution for a year or so - shows the pharma are prepared to move a little further down the food chain than was the case with AGPH.

This plus the GNE buyout/IPO should help the sector over the next few months. I think GNE is going to be a bigger deal for the sector than one might think - it might actually be a hot IPO if Roche doesn't get too greedy.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News